Slovakia vs South-East Asia (WHO region): Hypertension: effective treatment coverage (controlled hypertension)
Slovakia
36.1%
in 2019
South-East Asia (WHO region)
13.3%
in 2019
Slovakia rank
14th
South-East Asia (WHO region) rank
13th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Slovakia
- South-East Asia (WHO region)
How they compare
Slovakia currently reports 36.1% against 13.3% in South-East Asia (WHO region), a difference of 22.8%.
That makes Slovakia's figure about 2.7 times South-East Asia (WHO region)'s.
Across all 30 years both countries report, Slovakia has been ahead every year.
Slovakia ranks 14th and South-East Asia (WHO region) ranks 13th of 193 countries.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Slovakia | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 9.0% | 2.6% | 6.4% | Slovakia |
| 2000s | 18.4% | 5.7% | 12.7% | Slovakia |
| 2010s | 30.9% | 10.7% | 20.2% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Slovakia or South-East Asia (WHO region)?
- Slovakia, at 36.1% against 13.3% in South-East Asia (WHO region) as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Slovakia and South-East Asia (WHO region)?
- 22.8%, with Slovakia ahead.
- How many years of comparable data are there for Slovakia and South-East Asia (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do Slovakia and South-East Asia (WHO region) rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Slovakia ranks 14th and South-East Asia (WHO region) ranks 13th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.